Publications by authors named "Alev Turker"

Claim this Profile
I
Immune Checkpoint Molecule Expression, 9p24.1 Gene Alterations, and Tumor Microenvironment of Primary Central Nervous System Lymphomas and Their Clinical Relevance.
Dilara Akbulut, Seher Yuksel, Ekin Kircali, Burak Yasin Aktas, Secil Demirkol Canli, Alev Turker

Appl Immunohistochem Mol Morphol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab-induced leukocytoclastic vasculitis in a patient with low-grade orbital B-cell lymphoma: a case report.
Nesime İnci Güner, Ömer Dizdar, Alev Türker, Aygin Bayraktar-Ekincioglu

Anticancer Drugs· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarcopenia and anthracycline cardiotoxicity in patients with cancer.
Onur Bas, Ahmet Gurkan Erdemir, Mehmet Ruhi Onur, Necla Ozer, Yusuf Ziya Sener, Alev Turker

BMJ Support Palliat Care· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive value of tumoral DNA damage repair protein expression in patients with resected pancreatic cancer.
Furkan Ceylan, Deniz Can Guven, Hakan Taban, Oktay Aktepe, Taha Koray Sahin, Alev Turker

Clin Res Hepatol Gastroenterol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience.
Metin Demir, Denizcan Güven, Burak Yasin Aktaş, Gürkan Güner, Oktay Halit Aktepe

South Asian J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy analyses of axitinib and nivolumab in metastatic renal cell carcinoma after failure of targeted therapy: which is better?
Oktay Halit Aktepe, Fadime Sinem Ardic, Deniz Yuce, Deniz Can Guven, Gurkan Guner, Alev Turker

J BUON· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic.
Deniz Can Guven, Furkan Ceylan, Ibrahim Yahya Cakir, Engin Cesmeci, Basak Sayinalp, Alev Turker

Support Care Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.
Huseyin Bekoz, Murat Ozbalak, Nuri Karadurmus, Semra Paydas, Alev Turker

Ann Hematol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of lymph node status with survival and recurrence among women with endometrial cancer.
Osman Cagin Buldukoglu, Alev Turker, Alp Usubutun, Mehmet Coskun Salman

Int J Gynaecol Obstet· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 pandemic: changes in cancer admissions.
Deniz Can Guven, Burak Yasin Aktas, Melek Seren Aksun, Enes Ucgul, Taha Koray Sahin, Alev Turker

BMJ Support Palliat Care· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of clinical and PET-derived prognostic factors in patients with non-Hodgkin lymphoma: a special emphasis on bone marrow involvement.
Osman Kupik, Serkan Akin, Murat Tuncel, Gülnihan Eren, Alev Türker

Nucl Med Commun· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma.
Serkan Akin, Omer Dizdar, Yusuf Karakas, Alev Turker, Ayse Kars

Curr Probl Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute erythroid leukemia in a patient with chronic lymphocytic leukemia.
Deniz C Guven, Taner Babacan, Furkan Sarici, Serkan Akin, Kadri Altundag, Alev Turker

J BUON· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma.
Basak Oyan, Yener Koc, Evren Ozdemir, Ayse Kars, Alev Turker

Clin Transplant· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymic epithelial neoplasia: a study of 58 cases.
Emin Tamer Elkiran, Huseyin Abali, Sercan Aksoy, Kadri Altundag, Mustafa Erman, Alev Turker

Med Oncol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
Eser L Ergün, Pelin O Kara, Gonca K Gedik, Ayşe Kars, Alev Türker

Ann Nucl Med· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Craniospinal radiotherapy in adult medulloblastoma.
Ugur Selek, Faruk Zorlu, Pervin Hurmuz, Mustafa Cengiz, Alev Turker

Strahlenther Onkol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extensive exfoliative dermatitis induced by chlorambucil.
Saadettin Kilickap, Mevlut Kurt, Sercan Aksoy, Mustafa Erman, Alev Turker

Am J Hematol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma.
Basak Oyan, Yener Koc, Evren Ozdemir, Ayse Kars, Alev Turker

Leuk Lymphoma· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-Hodgkin lymphoma: a salvage regimen with high response rates before autologous stem cell transplantation.
Basak Oyan, Yener Koc, Evren Ozdemir, Ayse Kars, Alev Turker

Biol Blood Marrow Transplant· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Embryonal rhabdomyosarcoma of the larynx.
Oguz Dikbas, Kadri Altundag, Huseyin Abali, Alev Turker, Huseyin Engin

Otolaryngol Head Neck Surg· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IIVP salvage regimen induces high response rates in patients with relapsed lymphoma before autologous stem cell transplantation.
Huseyin Abali, Basak Oyan, Yener Koc, Ayse Kars, Ibrahim Barista, Alev Turker

Am J Clin Oncol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epithelioid sarcoma of vulva: a case report and review of the literature.
Kadri Altundag, Oguz Dikbas, Basak Oyan, Alp Usubutun, Alev Turker

Med Oncol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymic malignancy in a breast cancer patient--is there an association with anti-estrogenic effects of tamoxifen?
Başak Oyan, Sercan Aksoy, Ozlem Yavas, Ayse Kars, Alev Turker

Acta Oncol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual abdominal tumors, case 3. Primary omental T-cell lymphoblastic lymphoma.
Ozden Altundag, Ozlem Yavas, Kadri Altundag, Can Gonen, Alev Turker

J Clin Oncol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis